Significant change in ZAP‐70 expression during the course of chronic lymphocytic leukemia

Introduction:  It is widely accepted that expression of ZAP‐70 in chronic lymphocytic leukemia (CLL) remains stable in time. However, data supporting this notion are surprisingly scarce. Therefore, we assessed expression of ZAP‐70 in serial samples taken during the course of the disease.

[1]  J. Philippé,et al.  Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemia. , 2009, Leukemia research.

[2]  S. Johnson,et al.  ZAP-70 expression remains stable in chronic lymphocytic leukaemia. , 2007, International journal of laboratory hematology.

[3]  F. Ajchenbaum‐Cymbalista,et al.  National standardization of ZAP‐70 determination by flow cytometry: The French experience , 2007, Cytometry. Part B, Clinical cytometry.

[4]  P. Morel,et al.  Is ZAP-70 expression stable over time in B chronic lymphocytic leukaemia? , 2007, Leukemia & lymphoma.

[5]  F. Lo Coco,et al.  Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. , 2006, Blood.

[6]  N. Villamor,et al.  Evaluation of ZAP‐70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process , 2006, Cytometry. Part B, Clinical cytometry.

[7]  J. Roliński,et al.  Comparison of methods for determining zeta‐chain associated protein – 70 (ZAP‐70) expression in patients with B‐cell chronic lymphocytic leukemia (B‐CLL) , 2006, Cytometry. Part B, Clinical cytometry.

[8]  L. Klein-Hitpass,et al.  Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia , 2005, Leukemia.

[9]  Arthur Weiss,et al.  ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. , 2004, The New England journal of medicine.

[10]  Adrian Wiestner,et al.  ZAP-70 expression and prognosis in chronic lymphocytic leukaemia , 2004, The Lancet.

[11]  T. Möröy,et al.  ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia , 2003, Leukemia.

[12]  Emili Montserrat,et al.  ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. , 2003, The New England journal of medicine.

[13]  D. Oscier,et al.  CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. , 2002, Blood.

[14]  David Botstein,et al.  Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia , 2001, The Journal of experimental medicine.

[15]  K. Do,et al.  CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. , 2001, Blood.

[16]  N. Chiorazzi,et al.  Clinical and laboratory parameters that define clinically relevant B-CLL subgroups. , 2005, Current topics in microbiology and immunology.

[17]  D. Catovsky,et al.  CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia. , 2004, The hematology journal : the official journal of the European Haematology Association.

[18]  J. Dürig,et al.  CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia , 2002, Leukemia.

[19]  A. Weiss,et al.  Molecular and genetic insights into T cell antigen receptor signal transduction. , 1994, Advances in experimental medicine and biology.